Patents by Inventor Roslyn Dillon

Roslyn Dillon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200386759
    Abstract: Described herein are systems and methods for developing and utilizing assays for assessing health status such as colorectal cancer.
    Type: Application
    Filed: December 5, 2018
    Publication date: December 10, 2020
    Inventors: Bruce WILCOX, Lisa CRONER, Athit KAO, Jia YOU, Roslyn DILLON
  • Publication number: 20190257835
    Abstract: Disclosed herein are panels related to the diagnosis or recognition of colon and colorectal cancer in a subject. The disclosed panels and related methods are used to predict or assess colon tumor status in a patient. They can be used to determine nature of tumor, recurrence, or patient response to treatments. Some embodiments of the methods include generating a report for clinical management.
    Type: Application
    Filed: May 1, 2019
    Publication date: August 22, 2019
    Inventors: John Blume, Jeffrey Jones, Ryan Benz, Athit Kao, Lisa Croner, Roslyn Dillon, Jia You, Bruce Wilcox
  • Publication number: 20180100858
    Abstract: Disclosed herein are panels related to the diagnosis or recognition of advanced adenoma and colorectal cancer in a subject. The disclosed panels and related methods are used to predict or assess colon tumor status in a patient. They can be used to determine nature of tumor, recurrence, or patient response to treatments. Some embodiments of the methods include generating a report for clinical management.
    Type: Application
    Filed: January 24, 2017
    Publication date: April 12, 2018
    Inventors: John Blume, Athit Kao, Roslyn Dillon, Lisa Croner, Bruce Wilcox
  • Publication number: 20170370937
    Abstract: Disclosed herein are panels related to the diagnosis or recognition of colon and colorectal cancer in a subject. The disclosed panels and related methods are used to predict or assess colon tumor status in a patient. They can be used to determine nature of tumor, recurrence, or patient response to treatments. Some embodiments of the methods include generating a report for clinical management.
    Type: Application
    Filed: June 21, 2017
    Publication date: December 28, 2017
    Inventors: John Blume, Jeffrey Jones, Ryan Benz, Athit Kao, Lisa Croner, Roslyn Dillon, Jia You, Bruce Wilcox
  • Publication number: 20170285033
    Abstract: The disclosed methods are used to predict or assess colon tumor status in a patient. They can be used to determine nature of tumor, recurrence, or patient response to treatments. Some embodiments of the methods include generating a report for clinical management. The methodology provided herein is intended to detect technical variations and to allow for data normalization and enhance signal detection and build predictive proteins profiles of disease status and response.
    Type: Application
    Filed: June 14, 2017
    Publication date: October 5, 2017
    Inventors: John Blume, Ryan Benz, Lisa Croner, Roslyn Dillon, Arlo Z. Randall, Jeffrey Jones, Heather Skor, Tom Stockfisch, Bruce Wilcox, Daniel Ruderman
  • Patent number: 9689874
    Abstract: Disclosed herein are panels related to the diagnosis or recognition of colon and colorectal cancer in a subject. The disclosed panels and related methods are used to predict or assess colon tumor status in a patient. They can be used to determine nature of tumor, recurrence, or patient response to treatments. Some embodiments of the methods include generating a report for clinical management.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: June 27, 2017
    Assignee: APPLIED PROTEOMICS, INC.
    Inventors: John Blume, Jeffrey Jones, Ryan Benz, Athit Kao, Lisa Croner, Roslyn Dillon, Jia You, Bruce Wilcox
  • Publication number: 20170176441
    Abstract: Disclosed herein are panels related to the diagnosis or recognition of colon and colorectal cancer in a subject. The disclosed panels and related methods are used to predict or assess colon tumor status in a patient. They can be used to determine nature of tumor, recurrence, or patient response to treatments. Some embodiments of the methods include generating a report for clinical management.
    Type: Application
    Filed: March 27, 2015
    Publication date: June 22, 2017
    Inventors: John Blume, Ryan Benz, Lisa Croner, Roslyn Dillon, Jeffrey Jones, Athit Kao, Heather Skor, Bruce Wilcox
  • Publication number: 20160299144
    Abstract: Disclosed herein are panels related to the diagnosis or recognition of colon and colorectal cancer in a subject. The disclosed panels and related methods are used to predict or assess colon tumor status in a patient. They can be used to determine nature of tumor, recurrence, or patient response to treatments. Some embodiments of the methods include generating a report for clinical management.
    Type: Application
    Filed: April 8, 2016
    Publication date: October 13, 2016
    Inventors: John Blume, Jeffrey Jones, Ryan Benz, Athit Kao, Lisa Croner, Roslyn Dillon, Jia You, Bruce Wilcox
  • Publication number: 20150111223
    Abstract: The disclosed methods are used to predict or assess colon tumor status in a patient. They can be used to determine nature of tumor, recurrence, or patient response to treatments. Some embodiments of the methods include generating a report for clinical management. The methodology provided herein is intended to detect technical variations and to allow for data normalization and enhance signal detection and build predictive proteins profiles of disease status and response.
    Type: Application
    Filed: October 28, 2014
    Publication date: April 23, 2015
    Inventors: John Blume, Ryan Benz, Lisa Croner, Roslyn Dillon, Arlo Z. Randall, Jeffrey Jones, Heather Skor, Tom Stockfisch, Bruce Wilcox, Daniel Ruderman
  • Publication number: 20150111220
    Abstract: The disclosed methods are used to predict or assess colon tumor status in a patient. They can be used to determine nature of tumor, recurrence, or patient response to treatments. Some embodiments of the methods include generating a report for clinical management. The methodology provided herein is intended to detect technical variations and to allow for data normalization and enhance signal detection and build predictive proteins profiles of disease status and response.
    Type: Application
    Filed: October 28, 2014
    Publication date: April 23, 2015
    Inventors: John Blume, Ryan Benz, Lisa Croner, Roslyn Dillon, Arlo Z. Randall, Jeffrey Jones, Heather Skor, Tom Stockfisch, Bruce Wilcox, Daniel Ruderman
  • Publication number: 20150111221
    Abstract: The disclosed methods are used to predict or assess colon tumor status in a patient. They can be used to determine nature of tumor, recurrence, or patient response to treatments. Some embodiments of the methods include generating a report for clinical management. The methodology provided herein is intended to detect technical variations and to allow for data normalization and enhance signal detection and build predictive proteins profiles of disease status and response.
    Type: Application
    Filed: October 28, 2014
    Publication date: April 23, 2015
    Inventors: John Blume, Ryan Benz, Lisa Croner, Roslyn Dillon, Arlo Z. Randall, Jeffrey Jones, Heather Skor, Tom Stockfisch, Bruce Wilcox, Daniel Ruderman
  • Publication number: 20150111230
    Abstract: The disclosed methods are used to predict or assess colon tumor status in a patient. They can be used to determine nature of tumor, recurrence, or patient response to treatments. Some embodiments of the methods include generating a report for clinical management. The methodology provided herein is intended to detect technical variations and to allow for data normalization and enhance signal detection and build predictive proteins profiles of disease status and response.
    Type: Application
    Filed: October 28, 2014
    Publication date: April 23, 2015
    Inventors: John Blume, Ryan Benz, Lisa Croner, Roslyn Dillon, Arlo Z. Randall, Jeffrey Jones, Heather Skor, Tom Stockfisch, Bruce Wilcox, Daniel Ruderman
  • Publication number: 20140234854
    Abstract: The disclosed methods are used to predict or assess colon tumor status in a patient. They can be used to determine nature of tumor, recurrence, or patient response to treatments. Some embodiments of the methods include generating a report for clinical management. The methodology provided herein is intended to detect technical variations and to allow for data normalization and enhance signal detection and build predictive proteins profiles of disease status and response.
    Type: Application
    Filed: December 2, 2013
    Publication date: August 21, 2014
    Applicant: Applied Proteomics, Inc.
    Inventors: John Blume, Ryan Benz, Lisa Croner, Roslyn Dillon, Arlo Z. Randall, Jeffrey Jones, Heather Skor, Tom Stockfisch, Bruce Wilcox, Daniel Ruderman